Medicrea announces FDA clearance of first customizable interbody cages
Click Here to Manage Email Alerts
Medicrea announced its UNiD IB3D patient-matched interbody cages were cleared by the FDA, reportedly making it the first time this extent of customization has been commercially available for spinal devices.
The interbody cages, which are the final piece in the company’s UNiD Adaptive Spine Intelligence (ASI) platform technology, are 3D-printed titanium implants that vary by dimensions, features and endplate morphology depending on the patient. The cages are designed to match patients’ surgical and anatomical needs, as determined by UNiD lab engineers.
The cage is created through mapping the anatomy of each vertebrae endplate. When completed, according to the company, the cage restores proper height and angulation, and creates optimal surface contact between the implant and the endplates to improve the stability of the instrumented segment and to reduce subsidence.
Denys Sourmac, CEO and founder of Medicrea, said, “Medicrea’s recent FDA clearance reinforces its leading position in changing the spine industry by offering an alternative option for these very specific cases that did not have a personalized solution until now.”
Reference:
www.medicrea.com